Yasuo Suenaga
Beppu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 03, 2023
Outcomes and risk factors for mortality in Pneumocystis pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study.
Journal: Modern rheumatology
Published: June 14, 2022
Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study.
Journal: Arthritis research & therapy
Published: August 30, 2021
Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis.
Journal: Scandinavian journal of rheumatology
Published: May 15, 2020
Variant in the neuronal vesicular SNARE VAMP2 (synaptobrevin-2): First report in Japan.
Journal: Brain & development
Published: February 13, 2020
Brainstem infarction associated with HHV-6 infection in an infant.
Journal: Brain & development
Published: June 19, 2017
The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial.
Journal: Arthritis research & therapy
Published: May 26, 2016
Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
Journal: International journal of rheumatic diseases
Published: April 30, 2016
Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.
Journal: Medicine
Published: December 31, 2015
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.
Journal: Arthritis research & therapy
Published: July 09, 2015
Last Updated: 09/26/2026